T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr mice
暂无分享,去创建一个
[1] S. Muller,et al. Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. , 2002, Arthritis and rheumatism.
[2] R. Hoffman,et al. Apoptotic U1-70 kd is antigenically distinct from the intact form of the U1-70-kd molecule. , 2002, Arthritis and rheumatism.
[3] G. Steiner,et al. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice. , 2001, International immunology.
[4] H. Doyle,et al. Post-translational protein modifications in antigen recognition and autoimmunity. , 2001, Trends in immunology.
[5] S. Muller,et al. Key Sequences Involved in the Spreading of the Systemic Autoimmune Response to Spliceosomal Proteins , 2001, Scandinavian journal of immunology.
[6] S. Muller,et al. Laboratory protocols for the identification of Th cell epitopes on self-antigens in mice with systemic autoimmune diseases. , 2000, Journal of immunological methods.
[7] Ram Raj Singh,et al. The potential use of peptides and vaccination to treat systemic lupus erythematosus , 2000, Current opinion in rheumatology.
[8] M. Wener,et al. SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes. , 2000, Arthritis and rheumatism.
[9] C. Rugarli,et al. Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity. , 2000, Arthritis and rheumatism.
[10] H. Zinger,et al. Prevention of Systemic Lupus Erythematosus-Like Disease in (NZBxNZW)F1 Mice by Treating with CDR1- and CDR3-Based Peptides of a Pathogenic Autoantibody , 2000, Journal of Clinical Immunology.
[11] Menotti Ruvo,et al. Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide , 2000, Nature Biotechnology.
[12] R. Rodenburg,et al. Cell death: a trigger of autoimmunity? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] S. Muller,et al. B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4+ T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein , 2000, European journal of immunology.
[14] P. Anderson,et al. Death, autoantigen modifications, and tolerance , 2000, Arthritis research.
[15] A. Rosen,et al. Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status , 1999, The Journal of experimental medicine.
[16] L. Lu,et al. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. , 1999, The Journal of clinical investigation.
[17] S. Datta,et al. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. , 1999, Journal of immunology.
[18] J. Piette,et al. The key role of nucleosomes in lupus. , 1999, Arthritis and rheumatism.
[19] M. Piacentini,et al. Tissue transglutaminase: apoptosis versus autoimmunity. , 1999, Immunology today.
[20] P. Anderson,et al. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. , 1998, Arthritis and rheumatism.
[21] M F del Guercio,et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.
[22] P. Anderson,et al. Association of Phosphorylated Serine/Arginine (SR) Splicing Factors With The U1–Small Ribonucleoprotein (snRNP) Autoantigen Complex Accompanies Apoptotic Cell Death , 1998, The Journal of experimental medicine.
[23] R. Tisch,et al. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. , 1997, Immunology today.
[24] C. Leclerc,et al. In vivo T helper cell response to retro-inverso peptidomimetics. , 1997, Journal of immunology.
[25] F. Sinigaglia,et al. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. , 1997, Journal of immunology.
[26] P. Schur,et al. Proteins Phosphorylated during Stress-induced Apoptosis Are Common Targets for Autoantibody Production in Patients with Systemic Lupus Erythematosus , 1997, The Journal of experimental medicine.
[27] P. Allen,et al. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands , 1996, The Journal of experimental medicine.
[28] J. Berden,et al. Dual Reactivity of Several Monoclonal Anti-nucleosome Autoantibodies for Double-stranded DNA and a Short Segment of Histone H3* , 1996, The Journal of Biological Chemistry.
[29] M. Davis,et al. Altered T cell receptor ligands trigger a subset of early T cell signals. , 1996, Immunity.
[30] E. Tan,et al. Recent developments in the understanding of antinuclear autoantibodies. , 1996, International archives of allergy and immunology.
[31] P. Allen,et al. Essential flexibility in the T-cell recognition of antigen , 1996, Nature.
[32] E. Sercarz,et al. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. , 1995, The Journal of clinical investigation.
[33] L. Samelson,et al. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.
[34] Z. Nagy,et al. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.
[35] C. Janeway,et al. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. , 1994, Immunity.
[36] S. Kusumoto,et al. An Efficient Procedure for Solid-Phase Synthesis of Phosphopeptides by the Fmoc Strategy , 1994 .
[37] A. Rosen,et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.
[38] P. Allen,et al. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Briand,et al. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. , 1993, Peptide research.
[40] C. Will,et al. Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors. , 1993, Nucleic acids research.
[41] J. Tazi,et al. Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing , 1993, Nature.
[42] R. Germain,et al. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling , 1993, The Journal of experimental medicine.
[43] H. Grey,et al. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[44] H. Grey,et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor , 1992, Cell.
[45] R. Lührmann,et al. Characterisation of human and murine snRNP proteins by two-dimensional gel electrophoresis and phosphopeptide analysis of U1-specific 70K protein variants. , 1990, Nucleic acids research.
[46] J. Harley,et al. A MODEL FOR DISEASE HETEROGENEITY IN SYSTEMIC LUPUS ERYTHEMATOSUS: Relationships Between Histocompatibility Antigens, Autoantibodies, and Lymphopenia or Renal Disease , 1989, Arthritis and rheumatism.
[47] A. Steinberg,et al. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. , 1987, Annals of the rheumatic diseases.
[48] K. Elkon,et al. Apoptosis in rheumatic diseases. , 2000, The American journal of medicine.
[49] J. Levine,et al. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant. , 1999, Seminars in nephrology.
[50] D. Isenberg,et al. Apoptosis in human autoimmune diseases. , 1999, International reviews of immunology.
[51] A. Rosen,et al. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease , 1999, Cell Death and Differentiation.
[52] M. Bevan,et al. T cell receptor antagonists and partial agonists. , 1995, Immunity.